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Nathan Fernandez, MD, Ryan McEnaney, MD, Luke K. Marone, MD, Robert Y. Rhee, MD,
Steven Leers, MD, Michel Makaroun, MD, and Rabih A. Chaer, MD, Pittsburgh, Pa
Objective: The efficacy of tibial artery endovascular intervention (TAEI) for critical limb ischemia (CLI) and particularly
for wound healing is not fully defined. The purpose of this study is to determine predictors of failure and success for TAEI
in the setting of CLI.
Methods: All TAEI for tissue loss or rest pain (Rutherford classes 4, 5, and 6) from 2004 to 2008 were retrospectively
reviewed. Clinical outcomes and patency rates were analyzed by multivariable Cox proportional hazards regression and
life table analysis.
Results: One hundred twenty-three limbs in 111 patients (62% male, mean age 74) were treated. Sixty-seven percent of
patients were diabetics, 55% had renal insufficiency, and 21% required hemodialysis. One hundred two limbs (83%)
exhibited tissue loss; all others had ischemic rest pain. All patients underwent tibial angioplasty (PTA). Tibial excimer
laser atherectomy was performed in 14% of the patients. Interventions were performed on multiple tibial vessels in 20%
of limbs. Isolated tibial procedures were performed on 50 limbs (41%), while 73 patients had concurrent ipsilateral
superficial femoral artery or popliteal interventions. The mean distal popliteal and tibial runoff score improved from
11.8  3.6 to 6.7  1.6 (P < .001), and the mean ankle-brachial index increased from 0.61  0.26 to 0.85  0.22 (P <
.001). Surgical bypass was required in seven patients (6%). The mean follow up was 6.8  6.6 months, while the 1-year
primary, primary-assisted, and secondary patency rates were 33%, 50%, and 56% respectively. Limb salvage rate at 1 year
was 75%. Factors found to be associated with impaired limb salvage included renal insufficiency (hazard ratio [HR] 5.7;
P  .03) and the need for pedal intervention (HR  13.75; P  .04). TAEI in an isolated peroneal artery (odds ratio 
7.80; P  .01) was associated with impaired wound healing, whereas multilevel intervention (HR  2.1; P  .009) and
tibial laser atherectomy (HR 3.1; P .01) were predictors of wound healing. In patients with tissue loss, 41% achieved
complete closure (mean time to healing, 10.7 7.4 months), and 39% exhibited partial wound healing (mean follow up,
4.4  4.8 months) at last follow up. Diabetes, smoking, statin therapy, and revascularization of >1 tibial vessel had no
impact on limb salvage or wound healing. Re-intervention rate was 50% at 1 year.
Conclusions: TAEI is an effective treatment for CLI with acceptable limb salvage and wound healing rates, but requires a
high rate of reintervention. Patients with renal failure, pedal disease, or isolated peroneal runoff have poor outcomes with
TAEI and should be considered for surgical bypass. ( J Vasc Surg 2010;52:834-42.)Although patients with peripheral artery disease pre-
senting with critical limb ischemia (CLI; rest pain and tissue
loss, Rutherford classes 4, 5, 6) have been traditionally
treated with surgical bypass, advances in endovascular tech-
niques, including subintimal angioplasty, as well as ad-
vances in device technology, have allowed for the successful
treatment of more complex patterns of disease. Multiple
series have reported on the successful treatment of limb
threatening ischemia with endovascular interventions at the
femoral and popliteal levels.1-3
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834The recently published Trans Atlantic Inter-Societal
Consensus document (TASC II) promotes endovascular
techniques including angioplasty and stenting as first-line
therapy for symptomatic femoropopliteal stenotic or occlu-
sive lesions up to 10 cm in length.4 However, the recom-
mendations for infra-popliteal disease are not as clear be-
cause of limited data on the efficacy of tibial artery
endovascular intervention (TAEI) for CLI in terms of
wound healing and limb salvage. There are, however, sev-
eral recent reports of acceptable patency and limb salvage
rates with infrapopliteal interventions for the treatment of
CLI.5-7 This study sought to define predictors of success
and failure for TAEI in the treatment of critical limb
ischemia and, in particular, the ability of TAEI to achieve
wound healing and alleviate rest pain.
METHODS
Patient population. Patients who had undergone
infra-inguinal endovascular revascularization, which in-
cluded TAEI between September 2004 and October 2008
were retrospectively identified from a prospectively main-
tained database. Indications for treatment included rest
pain (Rutherford class 4) and/or tissue loss (Rutherford
class 5 and 6). Patients who presented with acute ischemia
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characteristics, co-morbidities, intervention sites, and com-
plications were recorded. Clinical outcomes, including pri-
mary patency, primary-assisted patency, secondary patency,
limb salvage, and wound healing rates were determined,
and preprocedure angiograms were reviewed to assess base-
line and postprocedural distal popliteal and tibial runoff.
Endovascular approach. It is the author’s primary
approach to attempt an endovascular intervention first in all
patients, regardless of anatomic limitations. Patients pre-
senting with CLI who cannot be treated by endovascular
intervention are offered surgical bypass or primary amputa-
tion, depending on the clinical picture. Some of the pa-
tients treated in this series, however, were referred by other
surgeons for an attempt at endovascular intervention be-
cause they were either medically high-risk for surgery or
had been determined to have no distal target for a bypass,
therefore representing a medical or anatomical high-risk
group. Some patients had a failed attempt at endovascular
recanalization, and these patients were not included in this
analysis.
All procedures were performed by vascular surgeons
using either a fixed-imaging hybrid operating room or in
the interventional angiography suite. All procedures were
performed under local anesthesia with moderate conscious
sedation. Contralateral retrograde common femoral access
was most commonly performed (78.5%), whereas ante-
grade ipsilateral access or trans-brachial access was selec-
tively used. Interventions were performed after systemic
heparinization (100 U/Kg).
All interventions were made with the intention of es-
tablishing in-line flow into the foot. Decisions on which
tibial vessels to treat were made primarily based on the
angiographic appearance. If a single revascularized vessel
did not appear to supply the area of tissue loss with in line
flow, then attempts at intervening on more than one tibial
vessel were made with the goal of establishing 1 vessel
runoff to the foot. If a single revascularized tibial vessel
appeared to supply the area of the wound, then further
attempts at tibial vessel revascularization were guided by
the ease of such an extra step based on lesion anatomy and
by the decision of the operating surgeon.
For complete occlusions, the lesions were crossed in a
subintimal plane, and re-entry was confirmed with contrast
injection prior to intervention. The wire primarily used is
the 0.35 floppy glide wire (Terumo Interventional Systems,
Somerset, NJ) along with the quickcross catheter (Spectra-
netics Corporation, Colorado Springs, Colo). While a sub-
intimal plane is often used primarily for femoropopliteal
lesions, an intraluminal plane is attempted first in tibial
lesions. As such, a subintimal plane was not commonly used
in tibial total occlusions; however, for short occlusions, it is
difficult to exactly determine whether any element of sub-
intimal passage had occurred.
Balloon diameter was selected based on the angio-
graphic measurements of the nondiseased arterial segment
proximal and distal to the lesion. Self-expanding stents
were implanted for femoropopliteal disease following bal-loon angioplasty and generally were placed for the treat-
ment of residual stenosis (30%) or flow limiting dissec-
tion, at the discretion of the operating surgeon. Stenting of
the origin of the superficial femoral artery, the retro and
infrageniculate popliteal artery, and the tibial vessels was
generally avoided. In addition to angioplasty, initial plaque
debulking of tibial lesions was performed with excimer laser
atherectomy (Spectranetics Corporation) at the discretion of the
operating surgeon. Excimer laser atherectomy was used in both
long tibial stenoses and total occlusions. This was done especially
for orifice or bifurcation lesions and to cross total occlusions in
cases of failure of wire passage, using the 0.9 probe and the
step-by-step technique. Interventions were performed with the
intention to treat all levels of disease in an attempt to obtain
in-line flow to the foot.
All patients undergoing endovascular intervention
were treated with an antiplatelet agent, either clopidogrel
or aspirin, unless there was a clear contraindication.
Definitions and classifications. Primary patency was
defined as the absence of restenosis, occlusion, or re-
intervention in the treated arterial segment. The primary
patency for any intervention ended when there was clear
evidence of occlusion on imaging, if there was a need for
repeat endovascular intervention, surgical bypass, or ampu-
tation. The need for re-intervention was based on either
a return of the patients symptoms with abnormal non-
invasive testing (ankle brachial index [ABI] decrease
0.15, dampened pulse volume recordings, or evidence of
stenosis by duplex ultrasound scan); duplex scan evidence
of recurrent disease alone or worsening of any patient’s
wound. The duplex ultrasound criteria utilized for the
detection of a hemodynamically significant restenosis in an
arterial segment previously treated with angioplasty were a
peak systolic velocity (PSV) of 300 cm/sec or a velocity
ratio (Vr) 3.0. The criteria utilized for the detection of a
significant (80%) in-stent stenosis were PSV 275 cm/
sec and a Vr 3.5.8 Noninvasive vascular laboratory sur-
veillance of the treated segments and tibial runoff was
performed at 1 month, 3 months, and 6 months post-
procedure. Patients were then evaluated at 6-month inter-
vals thereafter. When duplex evaluation was limited due to
artifact or body habitus, the toe pressures and quality of
PVR tracings were used as surrogates of adequacy of per-
fusion along with clinical evaluation of wounds and symp-
toms. Patients who were found to have asymptomatic
duplex evidence of tibial restenosis on follow up were
observed and only underwent repeat angiogram and at-
tempted re-intervention for recurrent symptoms.
Assisted primary patency was achieved via secondary
endovascular interventions to treat restenoses involving the
originally treated arterial segment. Additional procedures
to treat lesions proximal or distal to the initially treated
segment were also considered secondary interventions to
achieve primary-assisted patency. Secondary patency was
achieved utilizing secondary endoluminal procedures,
which involved recanalizing occluded arterial segments. In
those patients who went on to surgical bypass, any patency
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at the time of decision for bypass grafting.
Preprocedure popliteal and tibial runoff score were
calculated according to a modification of the Society for
Vascular Surgery (SVS) criteria, as previously published by
Davies et al.9 The pre- and postintervention angiographic
images for all patients included in the study were reviewed
in order to appropriately calculate the distal popliteal and
tibial runoff score. The three tibial vessels and the distal
popliteal artery were each assigned a score based on the
degree of disease. The individual vessel received a score of 0
for 20% stenosis, 1 for 21% to 49% stenosis, 2 for 50% to
99% stenosis, 2.5 for occlusion of less than half the length of
the vessel, and 3 for occlusion for more than half the length
of the vessel. Each tibial contributes 0 to 3 points to the
total score, and the popliteal score is multiplied by 3 with 1
point added to give additional weight to popliteal disease.
Therefore, a higher score indicates more severe disease, and
there is a maximum score of 19. Three runoff score groups
were identified: 5 (Good), 5 to 10 (Compromised), and
10 (Poor).
The wound care regimen was at the discretion of
the treating surgeon, who followed all wounds post-
intervention. In general, wound care with debridement was
performed at each outpatient visit as indicated, and wound
dimensional measurements were recorded. Necrotic tissue
was sharply debrided, and enzymatic debridement was only
offered to patients with evidence of minor fibrinous exu-
date on follow up or who could not tolerate office based
debridement. If the wound appeared infected with signs of
inflammation, systemic antibiotics were administered as
well as topical antibiotic therapy. Once the infection was
cleared, routine wound care was resumed.
Wound healing was considered poor when the
wounds were noted to be failing to improve by 4 weeks
from revascularization, if they were noted to be worsen-
ing/enlarging at the last documented follow up, or if
they progressed to major amputation. In general, pa-
tients noted to have worsening of their wounds but with
salvageable extremities were treated with repeat revascu-
larization.
Statistical analysis. An independent statistician per-
formed all advanced statistical analyses. Count data were
summarized as frequencies and continuous variables as
means  standard deviations. A paired t test was used to
evaluate changes in continuous variables. One-year primary
patency, primary-assisted patency, secondary patency, and
limb salvage were calculated by the Kaplan-Meier ap-
proach. All dependent variables were screened individually
with the outcome, and those that met a conservative re-
quirement (P  .30) were then moved forward to be
included in a multivariate model. Multivariable Cox pro-
portional hazards regression was used to develop predictive
models. Patients presenting with ischemic rest pain were
not included in the modeling for wound healing, but were
included in the modeling for limb salvage. Statistical Anal-
ysis Software (SAS) version 9.2 (Cary, NC) was used for the
statistical calculations.RESULTS
A total of 123 limbs in 111 patients underwent tibial
artery endovascular interventions. The mean age was
74 11.2 years, and 62% of patients were males. Comor-
bidities and risk factors are listed in Table I.
All interventions included a tibial artery angioplasty
with or without proximal intervention. All patients were
treated for critical limb ischemia; 102 limbs (83%) were
treated for tissue loss (Rutherford class 5 and 6 disease).
Fifty limbs (41%) underwent isolated tibial procedures,
while 73 limbs (59%) had concurrent ipsilateral superficial
femoral and/or popliteal artery intervention. Intervention
on1 tibial vessel was performed on 20% of limbs, and 14%
included selective tibial laser atherectomy. The types and
levels of primary interventions performed are outlined in
Table II. Moreover, 62% (76) of tibial interventions were
done for stenoses and 38% (47) for occlusions. In vessels
treated for total occlusion, 68% were categorized as short
(less than 1/3 the length of the vessel), 17% were catego-
rized as medium (1/3 to 2/3 the length of the treated
vessel), and 14% were categorized as long (2/3 the
length of the treated vessel).
Prior to intervention, 44% of the limbs treated had a
poor popliteal and tibial runoff score, 56% were compro-
mised, and none of the limbs were in the good range.
Postprocedurally, this improved to no limbs in the poor
range, 88% in the compromised range, and 12% in the good
range (Table III). The mean distal popliteal and tibial
runoff score improved from 11.8  3.6 preprocedure to
6.7 1.6 postprocedure (P .001), and this improvement
was similar for patients presenting with either rest pain or





Mean age (years) 74.1  11.2 (49-95)
Male 61% (68)
Diabetes mellitus 67% (74)
Chronic renal insufficiency 55% (60)
End-stage renal disease/dialysis 21% (24)
Hypertension 93% (102)
Hyperlipidemia 68% (72)
Prior coronary artery bypass graft 36% (39)
Coronary artery disease 72% (77)
Congestive heart failure 42% (43)
Angina 8% (8)
Unstable angina 1% (1)
History of myocardial infarction 38% (36)















†n103tissue loss. The mean ABI increased from 0.61  0.26
10
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.001).
Periprocedural complications included groin hema-
toma (2.5%), pseudoaneurysm formation (0.8%), acute re-
nal failure (0.8%), and the 30-day mortality was 1.7%
(Table IV). No patient developed any procedure-related
embolic complications. Two patients died within 30 days of
their procedure, one from complications of a groin hema-
toma after an antegrade access that required operative
repair and resulted in multisystem organ failure. The other
death was secondary to in-dwelling line infection and over-
whelming sepsis. The overall survival for the cohort was
83.7% at a mean follow-up time of 6.8 months.
At 1 year, the primary patency rate was 33%, and the
assisted primary patency rate, as maintained by additional
endovascular procedures, was 50%. Similarly, secondary
patency rates as maintained by additional endovascular
Table II. Summary of primary interventions
Primary interventions
Levels treated
Superficial femoral artery popliteal and tibial







Table III. Distal popliteal and tibial runoff scores for limb
Popliteal-tibial runoff score Good
Preprocedure 0
Postprocedure 12%
Table IV. Complications and length of stay for patients




Wound infection 0% (0)
Thrombosis 0% (0)
Acute renal failure 0.8% (1)
New or acute heart disease 0% (0)
Death
Within 30 days 1.7% (2)
Procedure-related 0.8% (1)
Mean length of stay (days) 3.1  5.4 (0-40)
Intensive care unit 4.1% (5)interventions were 56% (Fig 1).During the course of follow up, 39% of the patients
treated for tissue loss had improvement in their wounds
(mean follow up, 4.4  4.8 months), while 41% had
complete healing with amean time to healing of 10.7 7.4
months. TAEI in an isolated peroneal artery (odds ratio
[OR] 7.80; P .01) as well as the need for hemodialysis
(hazard ratio [HR]  5.63; P  .04) were associated with
impaired wound healing, whereas multi-level intervention
(HR 2.1; P .009) and selective tibial laser atherectomy
(HR  3.1; P  .01) were predictors of wound healing.
Overall, the limb salvage rate at 1 year was 75% (Fig 2).
Factors associated with limb loss at 1 year included chronic
renal insufficiency (HR  5.73; P  .03) and pedal inter-
vention (HR  13.75; P  .04). The limb salvage rate at
last follow up for those limbs that underwent an isolated
peroneal intervention versus other tibial intervention was
74% versus 80% (P .16). The limb salvage in patients with
end stage renal disease was 54% at the last follow up, and
was 82% for nondialysis–dependent patients (P  .15).
Diabetes, smoking, statin therapy, and revascularization of
1 tibial vessel had no impact on limb salvage or wound
healing. Patients who presented with ischemic rest pain
were not included in the analysis of factors affecting wound
healing; however, they were included in the analysis of limb
loss.
Life table analysis revealed a reintervention rate of 50%
at 1 year. Thirty-three patients underwent reintervention
during their follow-up; the main indications were failure of
wounds to heal (58%) and duplex evidence of re-stenosis in
the previously treated segment (24%; Table V). The types
of repeat interventions performed to maintain primary-
assisted and secondary patency are summarized in Table VI.





nsluminal angioplasty Stent Laser atherectomy
0% (50) 68% (34) 6% (3)
0% (56) 25% (14) 16% (9)
0% (123) 4% (5) 14% (17)
dergoing tibial artery interventions
Category
Meanompromised Poor
56% 44% 11.8  3.6







Cone of which went on to major amputation. These patients
oing tibial interventions (n  121).
b salvage in at-risk limbs.
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failed tibial re-intervention with no target for a bypass
progressed to major amputation. The mean preprocedure
Table V. Indications for reintervention on limbs
undergoing tibial artery interventions
Indication N  33
Failure of wound healing 58% (19)
Duplex evidence of recurrent stenosis 24% (8)
Recurrent ulceration 6% (2)
Recurrent rest pain 6% (2)
Other 6% (2)
Fig 1. Patency in limbs underg
Fig 2. Cumulative limpopliteal tibial runoff score for the four patients who pro-Table VI. Repeat interventions for maintenance of
patency (36 interventions in 33 limbs)
Primary
assisted patency
(n  25) % (n)
Secondary patency
(n  11) % (n)
Level of Intervention
Superficial femoral artery 40% (10) 36% (4)
Popliteal artery 44% (11) 46% (5)
Original tibial vessel 88% (22) 91% (10)
Alternate tibial vessel 32% (8) 18% (2)
Type of Intervention
Angioplasty 96% (24) 100% (11)
Laser atherectomy 16% (4) 27% (3)
Stenting 28% (7) 46% (5)
Cryoplasty 12% (3) 0
popli
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who had a subsequent bypass) was 14.6, and this improved
to 8.9 after their initial intervention. Of the patients who
failed re-intervention before progressing to amputation,
none of them lost their target as a result of the intervention.
These patients were not candidates for a bypass due to the
lack of a target vessel and were offered an anatomically
high-risk endovascular intervention for limb salvage as a last
resort effort.
DISCUSSION
Endovascular interventions for the treatment of critical
limb ischemia have become the first-line approach in many
centers.2,10,11 Tibial artery endovascular interventions in
the setting of CLI have been extensively described with
mixed results.1,12 A recent meta analysis by Romiti et al of
infrapopliteal angioplasty for the treatment of CLI showed
1-year primary and secondary patency rates of 58% and
68%, respectively, with a limb salvage rate of 86% and
patient survival of 98%.13 In the current study, we report a
primary patency at 1 year of 33% with a secondary patency
of 56% and a limb salvage rate of 75%. However, the
majority of the limbs (83%) were treated for tissue loss with
poor runoff scores and with limited target vessel options for
salvage with conversion to bypass, which may in part ex-
plain the somewhat lower rate of limb salvage in the current
series. Additionally, the lower rates of limb salvage are likely
due in part to the fact that several patients were offered an
endovascular intervention as a last resort effort, and most of
them did not have adequate pedal runoff.
In patients treated for tissue loss, complete wound
healing was achieved in 41% of cases with a mean time to
healing of 10.7 months. Additionally, 39% had improve-
ment in their wounds at last follow up, but 19% had
worsened tissue loss or required major amputation, while
1% remained unchanged. These rates of wound healing and
time to healing with TAEI are similar to those reported by
other groups.5 Giles et al recently reported on their expe-
rience with infrapopliteal angioplasty for CLI in 176 limbs.
At a mean follow up of 12 months, they reported complete
healing or improvement in 57% of limbs, with stable
wounds in 22% and worsening of the wound in 21%.5
One factor that may affect the rate of wound healing is
the degree of tissue loss present, in that a large volume of
Table VII. Summary of patients converted to surgical byp
Patient Initial intervention
1 PTA PT and plantar
2 PTA PT
3 PTA peroneal




AT, Anterior tibial artery; DP, dorsalis pedis artery; Fem, femoral; Pop,
amputation; TPT, tibial-peroneal trunk.tissue loss may predict failure of TAEI to achieve woundhealing. However, specific wound size information was not
available on enough patients to analyze this factor in the
current study. An additional confounder that may explain
the low healing rates is the length of follow up. In the
healed group, the mean time to healing was 10.7 months,
while the group that showed improvement in the wounds
had amean follow up of 4.4months. It is the authors’ belief
that with longer follow up, close surveillance, and repeat
interventions as indicated, improved wound healing rates
may be attainable.
In this series, multi-level interventions favorably af-
fected wound healing when compared with isolated TAEI,
but did not have a significant effect on overall limb salvage.
This may reflect to some degree an underestimation and
undertreatment of proximal disease in the isolated tibial
intervention group, where aggressive treatment of proximal
disease in the multi-level group would provide better flow
to the threatened foot. Although wound healing was not
directly evaluated in the meta-analysis by Romiti et al, there
was a trend toward better primary patency and limb salvage
with multi-level interventions compared with crural angio-
plasty alone.13 Wound healing was not included in the
report by Sadek et al, but they reported trends toward
improved limb salvage and primary patency, as well as
significantly improved secondary patency with multi-level
interventions involving the tibial vessels.10 One explana-
tion offered was that patients with single-level disease may
exhibit locally increased atherosclerotic burden compared
with patients with multilevel disease, and that this may
result in increased primary failure and need for secondary
interventions in patients with single-level infrapopliteal dis-
ease.
Selective laser atherectomy was found to have a positive
impact on wound healing, although it resulted in similar
patency rates. This technology has been utilized withmixed
early results with limb salvage rates at 12 months as low as
55% in some reports.14 In the current study, the use of laser
atherectomy was at the discretion of the operating surgeon,
and was primarily used for the debulking of calcified tibial
lesions prior to angioplasty. This was most commonly done
for orifice lesions, bifurcation lesions, and as an assist to
cross total occlusions. Importantly, laser atherectomy was
not used at any level as a stand-alone intervention, and was
followed by balloon angioplasty of the treated segment.
Bypass Outcome
Pop-AT bypass Healed toe amputation
Pop-DP bypass Healed toe amputation
Pop-Plantar bypass Healed ulcer
Fem-AT bypass Above knee amputation
Pop-DP bypass Healed ulcer
Fem-Peroneal bypass Healed toe amputation
Pop-Peroneal bypass Healed TMA
teal; PTA, percutaneous transluminal angioplasty; TMA, transmetatarsalass
ealThe number of limbs in the current series treated with
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wound healing may be a result of selection bias of the
treating surgeon as it was utilized in specific anatomic
situations, and it was used primarily to debulk calcified or
orifice lesions prior to balloon angioplasty. Given this bias,
the beneficial effects observed may not be widely applicable
and will need to be validated with a larger sample size.
Only patients who had completed successful endovas-
cular interventions were included in the study. Overall, 65%
of the treated limbs were felt to have angiographically
established in-line flow to the foot, and the remaining 35%
with an isolated peroneal artery intervention had either a
discontinuous or no pedal runoff, or communication to a
pedal runoff via peroneal collaterals at the ankle. The dis-
tribution of in-line pedal flowwas not different between the
groups that attained complete wound healing, had partial
healing, had worsening wounds, or that progressed to
major amputation. Among the factors found to negatively
affect wound healing included TAEI on an isolated pero-
neal artery. This may be related to the fact that, even with
successful treatment of the peroneal artery, in-line flow to
the foot is not established. Although it has been shown
that surgical bypass to the peroneal artery is an acceptable
option with good wound healing and limb salvage
rates,15,16 and that there is evidence that bypass to the
peroneal artery is not hemodynamically inferior to other
tibial artery bypass grafts,17 it remains to be determined if
the same is true for endovascular interventions. Dosluoglu
et al reported on their experience with endovascular inter-
ventions for limb salvage, comparing patients with isolated
peroneal artery runoff and those with other tibial runoff.
They noted similar patency and limb salvage rates between
the groups.18 They concluded that endovascular revascu-
larization of an isolated peroneal runoff resulted in accept-
able patency and limb salvage rates in patients presenting
with tissue loss. However, it is important to note that less
than half of the patients in their peroneal runoff group had
isolated infrapopliteal interventions, whichmight have con-
tributed to their positive outcomes.18 In contrast all pa-
tients in our study underwent isolated peroneal interven-
tions, and interventions on an isolated peroneal runoff were
done when there were no other options to improve outflow
to the foot. As such, the association of an isolated peroneal
intervention with poor wound healing is likely explained by
suboptimal pedal runoff, and possibly a greater local ath-
erosclerotic burden. In support of these findings, the up-
dated TASC-II guidelines state that for the endovascular
treatment of infra-popliteal disease, angioplasty may be
indicated for limb salvage, and the treatment of tibial artery
occlusion should be reserved for cases in which in-line flow
into the pedal vasculature can be established.4
However, peroneal interventions in our series did not
seem to affect limb salvage, and it may be that interventions
on an isolated peroneal runoff can result in limb salvage but
require longer follow up and prolonged wound care, since
pedal perfusion is likely improved via collateral pathways at
the ankle.In addition to renal insufficiency, interventions at the
pedal level were associated with an increased risk of limb
loss. On the other hand, patients on dialysis had similar
limb salvage as nondialysis patients. However, the number
of dialysis patients treated in this series was relatively small.
There is very little in the literature about the outcomes
of isolated pedal intervention and their effect on wound
healing and limb salvage. Although the numbers of such
patients treated in this series is small, it was predictive of
limb loss, and did not have a favorable effect on wound
healing. The association of pedal intervention with poor
outcomes is likely explained by poor patency and diffuse
inframalleolar small vessel disease, and may be a reflection
of a combination of overall greater burden of disease and
poor pedal runoff.
Alternatively, pedal bypass for limb salvage has been
shown to be an effective intervention for limb salvage, with
a recent meta-analysis showing 1-year and 5-year limb
salvage rates of 88% and 75%, respectively.19 Despite the
small numbers, and given our findings of impaired limb
salvage with pedal angioplasty, it is our current belief that
pedal bypass should be done preferentially over endovascu-
lar interventions for anatomically and physiologically suit-
able patients who require revascularization for isolated
distal tibial or pedal disease. Nevertheless, it is still our
practice to perform pedal interventions for patients who are
at a physiologically high risk for bypass.
Similarly, although our current report describes the
limitation of interventions on isolated peroneal runoff ves-
sels for wound healing, we do offer these interventions for
patients presenting with tissue loss who have good flow
into the foot via collateral pathways at the ankle. Patients
with a patent pedal vessel and poor collateralization from
the peroneal artery are preferentially offered a pedal bypass
if a vein conduit is available, and the patient has no prohib-
itive co-morbidities.
Although we are aggressive in our attempts at limb
salvage, in patients with extensive tissue loss and nonsal-
vageable limbs, such as dialysis patients with extensive heel
gangrene, a primary amputation is considered. Likewise,
nonambulatory patients with knee contractures and exten-
sive tissue loss are also offered a primary amputation.
In an attempt to quantify the disease burden treated at
the popliteal and tibial levels, we looked at preprocedure
angiograms and operative notes to assign a distal popliteal
and tibial runoff score. This was done according to a
modification of the SVS criteria such that a higher score
implies worse runoff and limb salvage rates.9 In the current
series, the mean distal popliteal and tibial runoff score
improved postintervention. This can be explained by the
fact that popliteal disease, when present, is weighted more
significantly than individual tibial vessels, and that the ma-
jority of the tibial interventions were done on a single tibial
vessel in an attempt to obtain in-line flow to the foot.
However, neither the preprocedural, postprocedural, or
change in runoff score were found to be associated with
wound healing or limb salvage rates. Moreover, 62% of
tibial interventions were done for stenoses and 38% for
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healing or limb salvage outcomes between these two
groups. Intuitively, although it would be expected that
total occlusions, particularly longer occlusions, would pre-
dict worse outcomes, the similar outcomes observed may
be due to the small number of patients and lack of power to
detect differences in subgroup analyses.
In the TASC II document, a classification for tibial
disease was not included, despite the fact that it was present
in the initial TASC document. The updated TASC-II
guidelines state that for the endovascular treatment of
infrapopliteal disease, angioplasty may be indicated for limb
salvage, but the classification was not updated given the
lack of supporting literature.4 For that reason, the current
study did not analyze data by TASC classification and used
the tibial runoff score instead.
All tibial interventions were performed with the intent
of establishing in-line flow into the foot. Several patients
underwent interventions on multiple tibials in an attempt
to maximize perfusion to the foot at the discretion of the
operating surgeon. Intervening on multiple tibial vessels
was not found to have any benefit in terms of wound
healing or limb salvage in the current analysis. The effect of
intervening in the same tibial bed at multiple levels was not
analyzed and cannot be correlated with limb outcomes.
Although diabetics constituted 67% of our patients,
this did not affect limb salvage or wound healing. There
have been mixed data reported in the literature on the
impact of diabetes on the outcomes of endovascular treat-
ment of CLI. Diabetes has been associated with impaired
primary patency rates requiring higher rates of reinterven-
tion in the treatment of infrainguinal occlusive disease in
patients presenting with both claudication and CLI.2 Sim-
ilarly, other series reported lower rates of limb salvage in
diabetics treated with endovascular interventions for CLI
despite attaining equivalent patency rates.20 However, oth-
ers showed that, although diabetics display decreased pri-
mary patency, with appropriate reintervention, improved
secondary patency and limb salvage rates can be attained.21
In the current study, diabetes was not a negative predictor
of wound healing or limb salvage. This likely reflects a
combination of our aggressive surveillance and reinterven-
tion protocols and possibly a patient selection bias as some
patients were referred by other surgeons only when they
were deemed to be at high risk for bypass, while other were
preferentially treated with a bypass.
There are several limitations to this study, primarily
inherent to its retrospective design. Additionally, as there
currently are no consensus guidelines to classify tibial inter-
ventions, the lack of reporting standards may yield mixed
results from different studies. In this retrospective single
institutional review, the approach to treatment of CLI was
left to the discretion of the operating surgeon. Where an
endovascular first approach was adopted by the majority,
others utilized TAEI only in patients with favorable anat-
omy or those deemed to be at high risk for surgical bypass.
Additionally different revascularization modalities and
techniques were operator-dependent, therefore resulting ina heterogenous patient population with different comor-
bidities and disease distribution.
Finally, longer follow up is needed to determine the
durability of TAEI and their long term effect on wound
healing and limb salvage, and larger cohort of patients are
required to compare the efficacy of the different available
endovascular modalities.
CONCLUSIONS
Tibial artery endovascular interventions result in ac-
ceptable rates of limb salvage and wound healing in an
often challenging patient population with compromised
tibial outflow. In addition, these interventions can be car-
ried out in situations when surgical bypass is not possible
due to severe medical risk factors. Pedal endovascular inter-
ventions had a negative impact on limb salvage, and pa-
tients with pedal disease distribution may be better treated
with a surgical bypass if medically and anatomically suitable.
Revascularization of multiple tibial vessels showed no ad-
ditional benefit over single tibial interventions, and isolated
peroneal interventions were found to be associated with
impaired wound healing. However, these findings will need
to be validated in larger series.
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